Extracellular vesicles and lipoproteins are lipid-based biological nanoparticles that play
important roles in (patho) physiology. Recent evidence suggests that extracellular vesicles …

Upon in vivo administration of nanoparticles, a protein corona forms on their surface and
affects their half-life in circulation, biodistribution properties, and stability; in turn, the …

In recent years, various approaches have been undertaken to eliminate lipoproteins co‐
isolated with extracellular vesicles, as they were initially regarded as contaminating entities …

At the dawn of a new nanotechnological era in the pharmaceutical field, it is very important
to examine and understand all the aspects that influence in vivo behaviour of nanoparticles …

Extracellular vesicles such as exosomes, microvesicles, apoptotic bodies, and large
oncosomes have been shown to participate in a wide variety of biological processes and are …

A thorough understanding of interactions occurring at the interface between nanocarriers
and biological systems is crucial to predict and interpret their biodistribution, targeting, and …

Extracellular vesicles contain a lipid bilayer membrane that protects the encapsulated
material, such as proteins, nucleic acids, lipids and metabolites, from the extracellular …

Extracellular vesicles (EVs) contribute to several pathophysiological processes and appear
as emerging targets for disease diagnosis and therapy. However, successful translation from …

The interactions between lipids and proteins are one of the most fundamental processes in
living organisms, responsible for critical cellular events ranging from replication, cell …

Over the past decade, a marked escalation in the prevalence of hepatic pathologies has
been observed, adversely impacting the quality of life for many. The predominant …